Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
A Multicenter, Randomized, Double-Masked, Sham-Controlled, Parallel-Group Phase 3 Study to Evaluate the Efficacy and Safety of Epithelium-On Corneal Cross-linking in Subjects 8 to 45 Years of Age With Keratoconus
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Active Treatment | Experimental | Epithelium-on corneal cross-linking |
|
| Control Treatment | Placebo Comparator | Placebo and sham for epithelium-on corneal cross-linking |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Riboflavin and Sodium Iodide solution and Ultraviolet-A treatment | Combination Product | Drug: Ribostat riboflavin and sodium iodide ophthalmic solution Device: UV-3000 ultraviolet A light source |
| Measure | Description | Time Frame |
|---|---|---|
| Best Spectacle-Corrected Distance Visual Acuity (BSCDVA) | BSCDVA will be assessed using Early Treatment Diabetic Retinopathy Study (ETDRS) visual acuity testing charts. The score ranges from 0 to 100, with a higher score representing better visual functioning. | Baseline to 12 months |
| Measure | Description | Time Frame |
|---|---|---|
| Vision-related Quality of Life as Assessed by the National Eye Institute 25-Item Visual Function Questionnaire (NEI-VFQ-25) | The score on the NEI-VFQ-25 ranges from 0 to 100, with a higher score indicating greater functioning. | Baseline to 12 months |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Michael Belin, MD | Epion Therapeutics | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Nvision Eye Centers Rowland Heights | Rowland Heights | California | 91748 | United States | ||
| Goodman Eye Center |
Not provided
Not provided
Not provided
Not provided
Not provided
| Placebo and sham treatment | Combination Product | Drug: placebo ophthalmic solution Device: UV-3000 light source |
|
| San Francisco |
| California |
| 94115 |
| United States |
| Center for Excellence in Eye Care | Miami | Florida | 33176 | United States |
| Chicago Cornea Consultants | Hoffman Estates | Illinois | 60169 | United States |
| Boston Vision | Brookline | Massachusetts | 02445 | United States |
| Ophthalmology Associates | St Louis | Missouri | 63131 | United States |
| The Eye Doctors at CNY Eye Care | East Syracuse | New York | 13057 | United States |
| Cincinnati Eye Institute | Cincinnati | Ohio | 45219 | United States |
| Devers Eye Institute | Portland | Oregon | 97210 | United States |
| Wills Eye Hospital | Philadelphia | Pennsylvania | 19107 | United States |
| UPMC Vision Institute | Pittsburgh | Pennsylvania | 15219 | United States |
| Baylor College of Medicine | Houston | Texas | 77030 | United States |
| University of Virginia | Charlottesville | Virginia | 22903 | United States |
| ID | Term |
|---|---|
| D007640 | Keratoconus |
| ID | Term |
|---|---|
| D003316 | Corneal Diseases |
| D005128 | Eye Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D012256 | Riboflavin |
| ID | Term |
|---|---|
| D005415 | Flavins |
| D011621 | Pteridines |
| D006574 | Heterocyclic Compounds, 2-Ring |
| D000072471 | Heterocyclic Compounds, Fused-Ring |
| D006571 | Heterocyclic Compounds |
| D006575 | Heterocyclic Compounds, 3-Ring |
| D003067 | Coenzymes |
| D045762 | Enzymes and Coenzymes |
| D010860 | Pigments, Biological |
| D001685 | Biological Factors |
Not provided
Not provided